Mustang Bio receives Nasdaq bid price deficiency notice; October 12, 2026 deadline
Mustang Bio received a Nasdaq notice on April 15, 2026, saying its common stock closed below $1.00 per share for 30 consecutive business days, so it is not in compliance with the minimum bid price rule. The notice has no immediate effect on the stock's listing, but the company has until October 12, 2026 to regain compliance, and there is no assurance it will keep its Nasdaq listing.
Key points
- Nasdaq notice received April 15, 2026; bid price closed below $1.00 for 30 consecutive business days
- Compliance deadline is October 12, 2026, a 180-calendar day grace period
- Compliance requires a closing bid price of at least $1.00 for a minimum of ten consecutive business days
- Company may be eligible for a second 180-day period or may need a reverse stock split; no decision has been made
The filing
Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 17, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.